Security key
230031106
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)
CUSIP: 230031106
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 33,862,280
- Total 13F value
- $762,265,836
- Share change
- +1,619,544
- SEC-reported price per share
- $22.57
- Number of holders
- 63
- Value change
- +$33,803,888
- Number of buys
- 39
- Number of sells
- 22
- Shares outstanding
- 61,676,366
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q3 2021
Institutions
63
Top holders
10
CGEM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
Cullinan Therapeutics, Inc. SEC filings
Cullinan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 230031106
Recent filing periods:
Ownership snapshot
Top reported holders of CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MPM BioImpact LLC
Disclosed value leader
MPM BioImpact LLC
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
MPM BioImpact LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
MPM BioImpact LLC
13%
Foresite Capital Management V, LLC
4.4%
CHI Advisors LLC
3.6%
FMR LLC
3.2%
BAUPOST GROUP LLC/MA
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
Company
|
13%
|
$203,783,000
7,913,887 shares
|
— | 30 Jun 2021 |
| Foresite Capital Management V, LLC |
13F
Company
|
4.4%
|
$70,334,000
2,731,410 shares
|
— | 30 Jun 2021 |
| CHI Advisors LLC |
13F
Company
|
3.6%
|
$57,753,000
2,242,841 shares
|
— | 30 Jun 2021 |
| FMR LLC |
13F
Company
|
3.2%
|
$50,931,000
1,977,907 shares
|
— | 30 Jun 2021 |
| BAUPOST GROUP LLC/MA |
13F
Company
|
3%
|
$46,277,000
1,835,560 shares
|
— | 30 Jun 2021 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
2.3%
|
$36,155,000
1,440,145 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
63
Shares
33,862,280
Rows available
63
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
70
Q3 2021 holders
63
Holder diff
-7
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend